John A. Ward

Array ( [id] => 1366444 [patent_doc_number] => 06570061 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Targeted replacement of an immunoglobulin gene without endogenous and selectable residual sequences in mice' [patent_app_type] => B1 [patent_app_number] => 08/403416 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 7803 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/570/06570061.pdf [firstpage_image] =>[orig_patent_app_number] => 08403416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4036085 [patent_doc_number] => 05994617 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Engraftment of immune-deficient mice with human cells' [patent_app_type] => 1 [patent_app_number] => 8/323587 [patent_app_country] => US [patent_app_date] => 1994-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 9300 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994617.pdf [firstpage_image] =>[orig_patent_app_number] => 323587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043257 [patent_doc_number] => 05874404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Immunoglobulin E receptor .alpha.-chain inhibits IgE production and secondary allergic responses' [patent_app_type] => 1 [patent_app_number] => 8/238027 [patent_app_country] => US [patent_app_date] => 1994-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11694 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874404.pdf [firstpage_image] =>[orig_patent_app_number] => 238027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1289219 [patent_doc_number] => 06632789 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Methods for modulating T cell responses by manipulating intracellular signal transduction' [patent_app_type] => B1 [patent_app_number] => 08/245282 [patent_app_country] => US [patent_app_date] => 1994-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9307 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632789.pdf [firstpage_image] =>[orig_patent_app_number] => 08245282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645932 [patent_doc_number] => 07119248 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof' [patent_app_type] => utility [patent_app_number] => 08/226168 [patent_app_country] => US [patent_app_date] => 1994-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7705 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119248.pdf [firstpage_image] =>[orig_patent_app_number] => 08226168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790359 [patent_doc_number] => 06984379 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood' [patent_app_type] => utility [patent_app_number] => 08/225478 [patent_app_country] => US [patent_app_date] => 1994-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 7868 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984379.pdf [firstpage_image] =>[orig_patent_app_number] => 08225478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409526 [patent_doc_number] => 06232522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Non-human animal model for systemic lupus erythematosis' [patent_app_type] => 1 [patent_app_number] => 8/160604 [patent_app_country] => US [patent_app_date] => 1993-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 27 [patent_no_of_words] => 12959 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232522.pdf [firstpage_image] =>[orig_patent_app_number] => 160604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84108 [patent_doc_number] => 07741465 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-22 [patent_title] => 'Chimeric receptor genes and cells transformed therewith' [patent_app_type] => utility [patent_app_number] => 08/084994 [patent_app_country] => US [patent_app_date] => 1993-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 59 [patent_no_of_words] => 15266 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741465.pdf [firstpage_image] =>[orig_patent_app_number] => 08084994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248890 [patent_doc_number] => 06673986 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Generation of xenogeneic antibodies' [patent_app_type] => B1 [patent_app_number] => 08/031801 [patent_app_country] => US [patent_app_date] => 1993-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 50 [patent_no_of_words] => 24366 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673986.pdf [firstpage_image] =>[orig_patent_app_number] => 08031801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600017 [patent_doc_number] => 06475787 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Method for producing monoclonal antibodies' [patent_app_type] => B1 [patent_app_number] => 07/765281 [patent_app_country] => US [patent_app_date] => 1991-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4227 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475787.pdf [firstpage_image] =>[orig_patent_app_number] => 07765281 [rel_patent_id] =>[rel_patent_doc_number] =>)